These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31092394)

  • 1. Enhanced Platelet Response to Clopidogrel in Zucker Diabetic Fatty Rats due to Impaired Clopidogrel Inactivation by Carboxylesterase 1 and Increased Exposure to Active Metabolite.
    Yao H; Bai R; Ren T; Wang Y; Gu J; Guo Y
    Drug Metab Dispos; 2019 Aug; 47(8):794-801. PubMed ID: 31092394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 diabetes mellitus decreases systemic exposure of clopidogrel active metabolite through upregulation of P-glycoprotein in rats.
    Yao H; Gu J; Shan Y; Wang Y; Chen X; Sun D; Guo Y
    Biochem Pharmacol; 2020 Oct; 180():114142. PubMed ID: 32653591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased plasma exposure of clopidogrel active metabolite in rats after long-term treatment with clopidogrel.
    Wang Y; Liu Y; Yao H; Chen X; Sun Y; Guo Y
    Biopharm Drug Dispos; 2023 Apr; 44(2):129-136. PubMed ID: 36905582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect Following Oral Administration to Coronary Artery Disease Patients With or Without Diabetes.
    Xu RJ; Kong WM; An XF; Zou JJ; Liu L; Liu XD
    Front Pharmacol; 2020; 11():593982. PubMed ID: 33519456
    [No Abstract]   [Full Text] [Related]  

  • 5. Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease.
    Angiolillo DJ; Jakubowski JA; Ferreiro JL; Tello-Montoliu A; Rollini F; Franchi F; Ueno M; Darlington A; Desai B; Moser BA; Sugidachi A; Guzman LA; Bass TA
    J Am Coll Cardiol; 2014 Sep; 64(10):1005-14. PubMed ID: 25190236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel's active metabolite.
    Sugidachi A; Ogawa T; Kurihara A; Hagihara K; Jakubowski JA; Hashimoto M; Niitsu Y; Asai F
    J Thromb Haemost; 2007 Jul; 5(7):1545-51. PubMed ID: 17456192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a physiology-directed population pharmacokinetic and pharmacodynamic model for characterizing the impact of genetic and demographic factors on clopidogrel response in healthy adults.
    Jiang XL; Samant S; Lewis JP; Horenstein RB; Shuldiner AR; Yerges-Armstrong LM; Peletier LA; Lesko LJ; Schmidt S
    Eur J Pharm Sci; 2016 Jan; 82():64-78. PubMed ID: 26524713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic expression of cytochrome P450 in Zucker diabetic fatty rats.
    Park SY; Kim CH; Lee JY; Jeon JS; Kim MJ; Chae SH; Kim HC; Oh SJ; Kim SK
    Food Chem Toxicol; 2016 Oct; 96():244-53. PubMed ID: 27523289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple cytochrome P450 isoforms are involved in the generation of a pharmacologically active thiol metabolite, whereas paraoxonase 1 and carboxylesterase 1 catalyze the formation of a thiol metabolite isomer from ticlopidine.
    Kim MJ; Jeong ES; Park JS; Lee SJ; Ghim JL; Choi CS; Shin JG; Kim DH
    Drug Metab Dispos; 2014 Jan; 42(1):141-52. PubMed ID: 24170778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel Resistance in a Murine Model of Diet-Induced Obesity Is Mediated by the Interleukin-1 Receptor and Overcome With DT-678.
    Sun Y; Venugopal J; Guo C; Fan Y; Li J; Gong Y; Chen YE; Zhang H; Eitzman DT
    Arterioscler Thromb Vasc Biol; 2020 Jun; 40(6):1533-1542. PubMed ID: 32268786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and competitive pharmacodynamics of ADP-induced platelet activation after oral administration of clopidogrel to horses.
    Norris JW; Watson JL; Tablin F; Kozikowski TA; Knych HK
    Am J Vet Res; 2019 May; 80(5):505-512. PubMed ID: 31034271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics-induced disruption of gut microbiota increases systemic exposure of clopidogrel active metabolite in type 2 diabetic rats.
    Chen X; Liu Y; Yao H; Song W; Song Y; Gu J; Guo Y
    Drug Metab Dispos; 2022 Jul; ():. PubMed ID: 35858690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting the activation of thienopyridines by cytochromes P450 using a pharmacodynamic assay in vitro.
    Abell LM; Liu EC
    J Pharmacol Exp Ther; 2011 Nov; 339(2):589-96. PubMed ID: 21828263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: a retrospective analysis of the FEATHER study.
    Jakubowski JA; Angiolillo DJ; Zhou C; Small DS; Moser BA; Ten Berg JM; Brown PB; James S; Winters KJ; Erlinge D
    Thromb Res; 2014 Sep; 134(3):552-7. PubMed ID: 25022828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Genetic Variants on Carboxylesterase 1 Gene Expression, and Clopidogrel Pharmacokinetics and Antiplatelet Effects.
    Neuvonen M; Tarkiainen EK; Tornio A; Hirvensalo P; Tapaninen T; Paile-Hyvärinen M; Itkonen MK; Holmberg MT; Kärjä V; Männistö VT; Neuvonen PJ; Pihlajamäki J; Backman JT; Niemi M
    Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):341-345. PubMed ID: 28990360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of gene expression profiles in insulin-sensitive tissues from pre-diabetic and diabetic Zucker diabetic fatty rats.
    Suh YH; Kim Y; Bang JH; Choi KS; Lee JW; Kim WH; Oh TJ; An S; Jung MH
    J Mol Endocrinol; 2005 Apr; 34(2):299-315. PubMed ID: 15821098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zucker Diabetic Fatty rats exhibit hypercoagulability and accelerated thrombus formation in the Arterio-Venous shunt model of thrombosis.
    Shang J; Chen Z; Wang M; Li Q; Feng W; Wu Y; Wu W; Graziano MP; Chintala M
    Thromb Res; 2014 Aug; 134(2):433-9. PubMed ID: 24796819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term standard alcohol consumption enhances platelet response to clopidogrel through inhibition of Nrf2/Ces1 pathway and induction of Cyp2c in mice.
    Ge PX; Jiang LP; Tai T; Zhu T; Ji JZ; Li YF; Mi QY; Xie HG
    Life Sci; 2021 Aug; 279():119268. PubMed ID: 33626394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite.
    Kazui M; Nishiya Y; Ishizuka T; Hagihara K; Farid NA; Okazaki O; Ikeda T; Kurihara A
    Drug Metab Dispos; 2010 Jan; 38(1):92-9. PubMed ID: 19812348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clopidogrel in Critically Ill Patients.
    Schoergenhofer C; Hobl EL; Schellongowski P; Heinz G; Speidl WS; Siller-Matula JM; Schmid M; Sunder-Plaßmann R; Stimpfl T; Hackl M; Jilma B
    Clin Pharmacol Ther; 2018 Feb; 103(2):217-223. PubMed ID: 28913918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.